Wang H, Wang R, Lakshmana MK, Nefzi A. Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents.
Bioorg Med Chem Lett 2014;
24:4384-4388. [PMID:
25155386 PMCID:
PMC4311522 DOI:
10.1016/j.bmcl.2014.08.022]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2014] [Revised: 08/04/2014] [Accepted: 08/06/2014] [Indexed: 11/17/2022]
Abstract
Alzheimer's disease is a persistent neurodegenerative disorder of elderly characterized clinically by irreversible loss of memory due to accumulation of amyloid beta peptides within the amyloid plaques. We report the parallel synthesis and screening results of diverse substituted di-thiazole piperazine benzamides. A new compound TPI-1917-49 was identified as a promising amyloid reducing agent by lowering the levels of Aβ at least in two cell types and in vivo.
Collapse